A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study
Open Access
- 10 November 2020
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy Nucleic Acids
- Vol. 23, 255-263
- https://doi.org/10.1016/j.omtn.2020.11.001
Abstract
No abstract availableFunding Information
- Ministerio de Economía y Competitividad
- Instituto de Salud Carlos III
- European Regional Development Fund
This publication has 46 references indexed in Scilit:
- GLIS3, a Susceptibility Gene for Type 1 and Type 2 Diabetes, Modulates Pancreatic Beta Cell Apoptosis via Regulation of a Splice Variant of the BH3-Only Protein BimPLoS Genetics, 2013
- GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer diseaseProgress in Neurobiology, 2011
- pROC: an open-source package for R and S+ to analyze and compare ROC curvesBMC Bioinformatics, 2011
- Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 DiabetesCirculation Research, 2010
- Inverse relation between FASN expression in human adipose tissue and the insulin resistance levelNutrition & Metabolism, 2010
- How Do We Define Cure of Diabetes?Diabetes Care, 2009
- Thrombospondin-1 Is an Adipokine Associated With Obesity, Adipose Inflammation, and Insulin ResistanceDiabetes, 2008
- Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of WomenDiabetes Care, 2007
- Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance TestDiabetes Care, 2007
- Evaluation of Simple Indices of Insulin Sensitivity and Insulin Secretion for Use in Epidemioiogic StudiesAmerican Journal of Epidemiology, 2000